menu
    • menu

    Company profile for Kura Oncology

    NEW Drugs in Dev: 4
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on the cancer’s genetic makeup. This new era of precision medicine offers the potential for innovative treatments that are safer and more effective for patients with certain can...
    At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on the cancer’s genetic makeup. This new era of precision medicine offers the potential for innovative treatments that are safer and more effective for patients with certain cancers. We are advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kura OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Kura Oncology, Inc. (Headquarters) 3033 Science Park Road, Suite 220 San Diego...
    Telephone
    Telephone
    (858) 500-8800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kuraoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kura Oncology Highlights KOMZIFTI Revenue, 2026 Milestones
    Kura Oncology Highlights KOMZIFTI Revenue, 2026 Milestones

    11 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/11/3216496/35186/en/Kura-Oncology-Highlights-Recent-Accomplishments-Preliminary-KOMZIFTI-Revenue-and-Anticipated-2026-Milestones.html

    GLOBENEWSWIRE
    11 Jan 2026
    Share Share
    Kura Oncology Reports Inducement Grants Under Nasdaq Rule
    Kura Oncology Reports Inducement Grants Under Nasdaq Rule

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212649/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Kura Oncology, Kyowa Kirin Present KOMZIFTI Data In AML
    Kura Oncology, Kyowa Kirin Present KOMZIFTI Data In AML

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201703/35186/en/Kura-Oncology-and-Kyowa-Kirin-Report-Combination-Data-for-KOMZIFTI-Ziftomenib-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-and-Relapsed-Refractory-AML.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Kura Oncology Hosts Investor Event On ASH 2025 Data
    Kura Oncology Hosts Investor Event On ASH 2025 Data

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198898/35186/en/Kura-Oncology-to-Host-Virtual-Investor-Event-to-Discuss-Data-Presented-at-ASH-2025-on-Triplet-Combination-of-Ziftomenib-KOMZIFTI-with-Venetoclax-and-Azacitidine-in-Newly-Diagnosed-.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Kura Oncology Nets $135M from First U.S. KOMZIFTI Sale
    Kura Oncology Nets $135M from First U.S. KOMZIFTI Sale

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197892/35186/en/First-U-S-Commercial-Sale-of-KOMZIFTI-Triggers-135-Million-Milestone-Payment-to-Kura-Oncology-Under-Collaboration-and-License-Agreement-with-Kyowa-Kirin.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    KOMZIFTI™ (Ziftomenib) Included In (NCCN) Guidelines For AML
    KOMZIFTI™ (Ziftomenib) Included In (NCCN) Guidelines For AML

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194795/35186/en/KOMZIFTI-ziftomenib-Added-to-National-Comprehensive-Cancer-Network-NCCN-Guidelines-for-Acute-Myeloid-Leukemia-AML.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search